In 2021, CCRM and CellCAN launched the Canadian Advanced Therapies Training Institute (CATTI) to address the talent shortage in Canada’s biomanufacturing workforce. Watch the video to learn more about CATTI’s best-in-class training programs, featuring (in order):

Craig Hasilo, Chief Scientific Officer, CATTI

Vanessa Laflamme, Chief Executive Officer, CATTI

Michael May, President and CEO, CCRM, and member of CATTI’s Board of Directors

William Brock, Chairman of the Board for CATTI and CellCAN

All other pages contact

For more information, please contact us.

Subscribe to our mailing list to receive CCRM’s monthly newsletter.


You have Successfully Subscribed!